NCT05740631 - The Effect of Obeticholic Acid in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 22, 2022

Primary Completion Date

July 22, 2023

Study Completion Date

July 22, 2023

Conditions

Healthy

Interventions

DRUG

Ocaliva

Assignment of treatment obeticholic acid will be started (randomized) after the study visit and administered orally in a single-blind fashion for 21 days.

DRUG

Placebo

Assignment of treatment placebo will be started (randomized) after the study visit and placebo will be administered orally in a single-blind fashion for 21 days.

Trial Locations (1)

3000

RECRUITING

KU Leuven, Leuven